
VetDC announces results from TANOVEA study in dogs with lymphoma
FORT COLLINS -- VetDC, Inc ., a veterinary cancer therapeutics company, today announced the successful conclusion of a new field study of Tanovea TM (rabacfosadine), a novel small molecule... Read More
Wednesday June 8, 2016